An in-depth look to SAMJIN PHARMACEUTICAL operating, investing, and financing activities

005500 free cash flow for Q3 24 is 2.28 B KRW. For 2023, 005500 free cash flow was -2.32 B KRW and operating cash flow was 8.33 B KRW.